• Drug repurposing accelerates cancer therapy development by leveraging existing safety data, reducing costs and time.
• Non-oncology drugs such as metformin, aspirin, and statins show promising anticancer effects across multiple cancer types.
• Repurposed drugs can overcome drug resistance and enhance the efficacy of conventional therapies.
• Regulatory and intellectual property challenges must be addressed to fully realize the clinical potential of drug repurposing.